MCK analyst estimates
McKesson (MCK) analyst ratings, the average price target and its range, and every firm's latest call.
MCK analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 20, 2026 | Mizuho Securities | McKesson price target raised to $1,020 from $905 at Mizuho | $1,020.00 |
| Oct 16, 2026 | UBS | McKesson price target raised to $1,200 from $1,080 at UBS | $1,200.00 |
| Oct 6, 2026 | Morgan Stanley | Morgan Stanley would like McKesson deal for Option Care Health | $977.00 |
| Aug 19, 2026 | RBC Capital | RBC Capital Starts McKesson (MCK) at Sector Perform | $845.00 |
| Aug 19, 2026 | Barclays | McKesson price target raised to $1,000 from $925 at Barclays | $1,000.00 |
| Aug 11, 2026 | Wells Fargo | McKesson (MCK) PT Raised to $933 at Wells Fargo | $933.00 |
| Aug 6, 2026 | Robert W. Baird | McKesson price target raised to $1,015 from $955 at Baird | $1,015.00 |
| May 8, 2026 | Deutsche Bank | McKesson price target lowered to $875 from $973 at Deutsche Bank | $875.00 |
| May 8, 2026 | UBS | McKesson price target raised to $1,050 from $1,000 at UBS | $1,050.00 |
| Mar 5, 2026 | Leerink Partners | Leerink Partners Reiterates Outperform Rating on McKesson (MCK) following CFO retirement announcement | $1,085.00 |
| Mar 5, 2026 | Raymond James | BofA Securities Reiterates Buy Rating on McKesson (MCK) amid CFO retirement | $970.00 |
| Feb 18, 2026 | Barclays | McKesson price target raised to $1,050 from $960 at Barclays | $1,050.00 |
| Jan 29, 2026 | Morgan Stanley | McKesson price target raised to $966 from $916 at Morgan Stanley | $966.00 |
| Jan 14, 2026 | Robert W. Baird | McKesson price target raised to $968 from $928 at Baird | $968.00 |
| Dec 8, 2025 | Barclays | McKesson initiated with an Overweight at Barclays | $960.00 |
- 14 firms rate MCK: 11 buy, 3 hold, 0 sell.
- The average price target is $983.12 from 8 analysts, from $845.00 to $1,200.00.
Updated 2026-11-02 17:53 UTC